Vascular endothelial growth factor - SciosAlternative Names: VEGF-121
Latest Information Update: 01 May 2003
At a glance
- Originator Scios
- Class Growth factors
- Mechanism of Action Angiogenesis inducing agents
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Vascular disorders
Most Recent Events
- 26 Nov 1999 Vascular endothelial growth factor - Scios is available for licensing
- 04 Oct 1999 Preclinical development for Vascular disorders in USA (Unknown route)